Identification of clinical phenotypes in schizophrenia: the role of lurasidone
The treatment of schizophrenia includes the control of symptoms, the prevention of relapses, and amelioration of adaptive skills for patient re-integration into society. Antipsychotic drugs are the agents of choice for the treatment of schizophrenia, as they reduce the positive symptoms of psychosis...
Saved in:
Main Authors: | Marco Andrea Riva (Author), Umberto Albert (Author), Sergio de Filippis (Author), Antonio Vita (Author), Domenico De Berardis (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical potential of lurasidone in the management of schizophrenia
by: Samalin L, et al.
Published: (2011) -
Lurasidone for the treatment of schizophrenia in adult and paediatric populations
by: Teresa Guilera, et al.
Published: (2023) -
Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
by: Miura I, et al.
Published: (2023) -
Update on the development of lurasidone as a treatment for patients with acute schizophrenia
by: Yasui-Furukori N
Published: (2012) -
Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China
by: Jia Liu, et al.
Published: (2022)